Rehabilitation and Pharmacotherapy of Neuromyelitis Optica Spectrum Disorder: A case Report

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background Neuromyelitis optica spectrum disorder (NMOSD) is a demyelinating autoimmune disease that affects the central nervous system. It typically manifests as optic neuritis or extensive longitudinal myelitis, with or without the presence of anti-aquaporin protein 4 autoantibodies (immunoglobulin G). Case Summary We report the case of a 45-year-old woman with a history of Sjogren's syndrome who was diagnosed with NMOSD accompanied by spinal cord injury and left calf intermuscular vein thrombosis. The patient received hormone shock and gamma globulin therapy in the acute phase and standard rehabilitation treatment during convalescence. Upon discharge, the patient was able to control urination and defecation, stand independently, and walk short distances with the aid of a walker. Conclusion This case suggests that pharmacotherapy and standard rehabilitation treatment can improve the prognosis of NMSOD patients.

Cite

CITATION STYLE

APA

Wang, X. J., Xia, P., Yang, T., Cheng, K., Chen, A. L., & Li, X. P. (2021). Rehabilitation and Pharmacotherapy of Neuromyelitis Optica Spectrum Disorder: A case Report. World Journal of Clinical Cases, 9(16), 3951–3959. https://doi.org/10.12998/wjcc.v9.i16.3951

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free